Cerebral vasculopathy in children with sickle cell anemia

Blood Cells, Molecules, and Diseases

Volumn 54, Issue 1, 2015, Pages 17-25

  Fasano, Ross M ^a,b   Meier, Emily R ^a,b   Hulbert, Monica L ^c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral vasculopathy; Moyamoya; Sickle cell anemia; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; DEFERASIROX; HYDROXYUREA;

ACUTE CHEST SYNDROME; ALLOIMMUNIZATION; ALPHA THALASSEMIA; ARTERY ENDOTHELIUM; BLOOD CLOTTING; BRAIN HEMORRHAGE; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; DISEASE COURSE; DOPPLER ECHOGRAPHY; ENDOTHELIUM INJURY; ERYTHROCYTE; FOLLOW UP; GENETIC ASSOCIATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOXEMIA; INFLAMMATION; IRON OVERLOAD; MAGNETIC RESONANCE ANGIOGRAPHY; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHLEBOTOMY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; RISK REDUCTION; SEIZURE; SENSITIVITY AND SPECIFICITY; SICKLE CELL ANEMIA; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; ANEMIA, SICKLE CELL; CHILD; COMPLICATION; ERYTHROCYTE DISORDER; FEMALE; INCIDENCE; MALE; METABOLISM; PRESCHOOL CHILD; STROKE; VASCULITIS, CENTRAL NERVOUS SYSTEM;

ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES, ABNORMAL; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; MALE; STROKE; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 84926974870     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2014.08.007     Document Type: Review

References (91)

1. Broderick J., Talbot G.T., Prenger E., Leach A., Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J. Child Neurol. Jul 1993, 8(3):250-255.
2. Ohene-Frempong K., Weiner S.J., Sleeper L.A., et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998, 91(1):288-294.
3. Bridgers W.H. Cerebral vascular disease accompanying sickle cell anemia. Am. J. Pathol. May 1939, 15(3):353-362. (355).
4. Pegelow C.H., Macklin E.A., Moser F.G., et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002, 99(8):3014-3018.
5. DeBaun M.R., Sarnaik S.A., Rodeghier M.J., et al. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood 2012, 119(16):3684-3690.
6. Bernaudin F., Verlhac S., Arnaud C., et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 2011, 117(4):1130-1140.
7. Suzuki J., Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch. Neurol. 1969, 20(3):288-299.
8. Rothman S.M., Fulling K.H., Nelson J.S. Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann. Neurol. 1986, 20(6):684-690.
9. Stockman J.A., Nigro M.A., Mishkin M.M., Oski F.A. Occlusion of large cerebral vessels in sickle-cell anemia. N. Engl. J. Med. 1972, 287(17):846-849.
10. Boros L., Thomas C., Weiner W.J. Large cerebral vessel disease in sickle cell anemia. J. Neurol. Neurosurg. Psychiatry 1976, 39:1236-1239.
11. Merkel K.H., Ginsberg P.L., Parker J.C., Post M.J. Cerebrovascular disease in sickle cell anemia: a clinical, pathological, and radiological correlation. Stroke 1978, 9:45-52.
12. Prengler M., Pavlakis S.G., Prohovnik I., Adams R.J. Sickle cell disease: the neurological complications. Ann. Neurol. 2002, 51(5):543-552.
13. Chang Milbauer L., Wei P., Enenstein J., et al. Genetic endothelial systems biology of sickle stroke risk. Blood 2008, 111(7):3872-3879.
14. Coates T.D. So what if blood is thicker than water?. Blood 2011, 117(3):745-746.
15. Driscoll M.C., Hurlet A., Styles L., et al. Stroke risk in siblings with sickle cell anemia. Blood 2003, 101(6):2401-2404.
16. Kwiatkowski J.L., Hunter J.V., Smith-Whitley K., Katz M.L., Shults J., Ohene-Frempong K. Transcranial Doppler ultrasonography in siblings with sickle cell disease. Br. J. Haematol. Jun 2003, 121(6):932-937.
17. Sarnaik S.A., Ballas S.K. Molecular characteristics of pediatric patients with sickle cell anemia and stroke. Am. J. Hematol. Jul 2001, 67(3):179-182.
18. Bernaudin F., Verlhac S., Chevret S., et al. G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood 2008, 112(10):4314-4317.
19. Belisario A.R., Martins M.L., Brito A.M., Rodrigues C.V., Silva C.M., Viana M.B. Beta-globin gene cluster haplotypes in a cohort of 221 children with sickle cell anemia or Sbeta(0)-thalassemia and their association with clinical and hematological features. Acta Haematol. 2010, 124(3):162-170.
20. Flanagan J.M., Frohlich D.M., Howard T.A., et al. Genetic predictors for stroke in children with sickle cell anemia. Blood 2011, 117(24):6681-6684.
21. Sebastiani P., Ramoni M.F., Nolan V., Baldwin C.T., Steinberg M.H. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat. Genet. Apr 2005, 37(4):435-440.
22. Flanagan J.M., Sheehan V., Linder H., et al. Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood 2013, 121(16):3237-3245.
23. Lettre G. The search for genetic modifiers of disease severity in the beta-hemoglobinopathies. Cold Spring Harb. Perspect. Med. Oct 2012, 2(10):1-12.
24. Kinney T.R., Sleeper L.A., Wang W.C., et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 1999, 103(3):640-645.
25. Miller S.T., Sleeper L.A., Pegelow C.H., et al. Prediction of adverse outcomes in children with sickle cell disease. N. Engl. J. Med. 2000, 342(2):83-89.
26. Quinn C.T., Lee N.J., Shull E.P., Ahmad N., Rogers Z.R., Buchanan G.R. Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort. Blood 2008, 111(2):544-548.
27. Abboud M.R., Cure J., Granger S., et al. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood 2004, 103(7):2822-2826.
28. Thangarajh M., Yang G., Fuchs D., et al. Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-dehydrogenase mutation in children with sickle cell anemia. Br. J. Hematol. 2012, 159(3):352-359.
29. Adams R.J. Big strokes in small persons. Arch. Neurol. 2007, 64(11):1567-1574.
30. Dobson S.R., Holden K.R., Nietert P.J., et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002, 99(9):3144-3150.
31. Hulbert M.L., McKinstry R.C., Lacey J.L., et al. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood 2011, 117(3):772-779.
32. Adams R., McKie V., Nichols F., et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N. Engl. J. Med. 1992, 326(9):605-610.
33. Adams R.J., McKie V.C., Carl E.M., et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann. Neurol. 1997, 42(5):699-704.
34. Pegelow C.H., Wang W., Granger S., et al. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch. Neurol. 2001, 58:2017-2021.
35. Miller S.T., Macklin E.A., Pegelow C.H., et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J. Pediatr. 2001, 139(3):385-390.
36. Prohovnik I., Hurlet-Jensen A., Adams R., De Vivo D., Pavlakis S.G. Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease. J. Cereb. Blood Flow Metab. 2009, 29(4):803-810.
37. Lin N., Baird L., Koss M., et al. Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression. Neurosurg. Focus. Dec 2011, 31(6):E6.
38. Seibert J.J., Glasier C.M., Kirby R.S., et al. Transcranial Doppler, MRA, and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia: an 8-year study. Pediatr. Radiol. 1998, 28(3):138-142.
39. Russell M.O., Goldberg H.I., Reis L., et al. Transfusion therapy for cerebrovascular abnormalities in sickle cell disease. J. Pediatr. 1976, 88(3):382-387.
40. Russell M.O., Goldberg H.I., Hodson A., et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 1984, 63(1):162-169.
41. Lusher J.M., Haghighat H., Khalifa A.S. A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction. Am. J. Hematol. 1976, 1(2):265-273.
42. Scothorn D.J., Price C., Schwartz D., et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J. Pediatr. 2002, 140(3):48-54.
43. Pegelow C.H., Adams R.J., McKie V., et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J. Pediatr. 1995, 126(6):896-899.
44. Adams R.J., McKie V.C., Hsu L., et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N. Engl. J. Med. 1998, 339(1):5-11.
45. Adams R.J., Brambilla D. Optimizing Primary Stroke Prevention in Sickle Cell Anemia Trial I. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N. Engl. J. Med. 2005, 353(26):2769-2778.
46. Fullerton H.J., Adams R.J., Zhao S., Johnston S.C. Declining stroke rates in Californian children with sickle cell disease. Blood 2004, 104(2):336-339.
47. McCarville M.B., Goodin G.S., Fortner G., et al. Evaluation of a comprehensive transcranial Doppler screening program for children with sickle cell anemia. Pediatr. Blood Cancer 2008, 50(4):818-821.
48. Bernaudin F., Verlhac S., Coic L., Lesprit E., Brugieres P., Reinert P. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr. Radiol. 2005, 35(3):242-248.
49. Platt O.S. Preventing stroke in sickle cell anemia. N. Engl. J. Med. 2005, 353(26):2743-2745.
50. Bader-Meunier B., Verlhac S., Elmaleh-Berges M., et al. Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia. Hematologica 2009, 94(1):123-126.
51. Brousse V., Hertz-Pannier L., Consigny Y., et al. Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease?. Ann. Hematol. 2009, 88(8):785-788.
52. Bishop S., Matheus M.G., Abboud M., et al. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells Mol. Dis. 2011, 47:125-128.
53. Gyang E., Yeom K., Hoppe C., Partap S., Jeng M. Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease. Am. J. Hematol. 2011, 86(1):104-106.
54. Sheehan V.A., Hansbury E.N., Smeltzer M.P., Fortner G., McCarville M.B., Aygun B. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke. Pediatr. Blood Cancer Sep 2013, 60(9):1499-1502.
55. Ware R.E., Schultz W.H., Yovetich N., et al. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Pediatr. Blood Cancer 2011, 57(6):1011-1017.
56. Ware R.E., Helms R.W. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH). Blood 2012, 119(17):3925-3932.
57. Kratovil T., Bulas D., Driscoll M.C., Speller-Brown B., McCarter R., Minniti C.P. Hydroxyurea therapy lowers TCD velocities in children with sickle cell disease. Pediatr. Blood Cancer 2006, 47(7):894-900.
58. Zimmerman S.A., Schultz W.H., Burgett S., Mortier N.A., Ware R.E. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Blood 2007, 110(3):1043-1047.
59. Brousse V., Gandhi S., de Montalembert M., et al. Combined blood transfusion and hydroxycarbamide in children with sickle cell anemia. Br. J. Haematol. 2013, 160(2):259-261.
60. Walters M.C., Storb R., Patience M., et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood 2000, 95:1918-1924.
61. Bernaudin F., Socie G., Kuentz M., et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007, 110:2749-2756.
62. Kamani N.R., Walters M.C., Carter S., et al. Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol. Blood. Marrow Transplant. 2012, 18(8):1265-1272.
63. Walters M.C., Hardy K., Edwards S., et al. Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol. Blood. Marrow Transplant. Feb 2010, 16(2):263-272.
64. Woodard P., Helton K.J., Khan R.B., et al. Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. Br. J. Haematol. 2005, 129:550-552.
65. Scott R.M., Smith E.R. Moyamoya disease and moyamoya syndrome. N. Engl. J. Med. 2009, 360(12):1226-1237.
66. Fryer R.H., Anderson R.C., Chiriboga C.A., Feldstein N.A. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. Pediatr. Neurol. 2003, 29(2):124-130.
67. Hankinson T.C., Bohman L.-E., Heyer G., et al. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis. J. Neurosurg. Pediatr. March 2008, 1(3):211-216.
68. Smith E.R., McClain C.D., Heeney M., Scott R.M. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg. Focus. 2009, 26(4).
69. Kennedy B.C., McDowell M.M., Yang P.H., et al. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases. Neurosurg. Focus. 2014, 36(1).
70. O'Brien E., Leonard J., Guilliams K., Fallon R., Hulbert M. Outcomes of children with Sickle cell disease and moyamoya with and without cerebral revascularization surgery. Pediatr. Blood Cancer 2014, 61(S1):S59.
71. Lebensburger J.D., Bemrich-Stolz C.J., Griessenauer C., et al. Encephaloduroarteriosynangiosis (EDAS) for patients with sickle cell disease. Blood 2013, 122(21):999.
72. Roach E.S., Golomb M.R., Adams R., et al. Management of stroke in infants and children: a scientific statement from a special writing group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008, 39:2644-2691.
73. Greenberg J., Ohene-Frempong K., Halus J., Way C., Schwartz E. Trial of low doses of aspirin as prophylaxis in sickle cell disease. J. Pediatr. 1983, 102(5):781-784.
74. Strouse J.J., Hulbert M.L., DeBaun M.R., Jordan L.C., Casella J.F. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics 2006, 118:1916-1924.
75. Jones A.M., Seibert J.J., Nichols F.T., et al. Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia. Pediatr. Radiol. Jul 2001, 31(7):461-469.
76. McCarville M.B., Li C., Xiong X., Wang W. Comparison of transcranial Doppler sonography with and without imaging in the evaluation of children with sickle cell anemia. AJR Am. J. Roentgenol. Oct 2004, 183(4):1117-1122.
77. Adams R.J., Nichols F.T., Figueroa R., McKie V., Lott T. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke 1992, 23(8):1073-1077.
78. Buchanan I.D., James-Herry A., Osunkwo I. The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease. J. Pediatr. Hematol. Oncol. 2013, 35(7):543-546.
79. Kwiatkowski J.L., Granger S., Brambilla D.J., et al. Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. Br. J. Haematol. Aug 2006, 134(3):333-339.
80. Minniti C.P., Gidvani V.K., Bulas D., Brown W.A., Vezina G., Driscoll M.C. Transcranial Doppler changes in children with sickle cell disease on transfusion therapy. J. Pediatr. Hematol. Oncol. Oct 2004, 26(10):626-630.
81. Zimmerman R.A. MRI/MRA evaluation of sickle cell disease of the brain. Pediatr. Radiol. Mar 2005, 35(3):249-257.
82. Helton K.J., Adams R.J., Kesler K.L., et al. Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial. Blood 2014, 124(6):891-898.
83. DeBaun M.R., Gordon M., McKinstry R.C., et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N. Engl. J. Med. 2014, 371(8):699-710.
84. Ware R.E. How I, use hydroxyurea to treat young patients with sickle cell anemia. Blood 2010, 115(26):5300-5311.
85. Steinberg M.H. More blood for sickle cell anemia?. N. Engl. J. Med. 2014, 371(8):775-776.
86. Hulbert M.L., Ford A.L. Understanding sickle cell brain drain. Blood 2014, 124(6):830-831.
87. Sheth S., Licursi M., Bhatia M. Sickle cell disease: time for a closer look at treatment options?. Br. J. Haematol. 2013, 162(4):455-464.
88. King A., Shenoy S. Evidence-based focused review of the status of hematopoietic stem cell transplantation as treatment of sickle cell disease and thalassemia. Blood 2014, 123(20):3089-3094.
89. Nickel R.S., Hendrickson J.E., Haight A.E. The ethics of a proposed study of hematopoietic stem cell transplant for children with "less severe" sickle cell disease. Blood 2014, 124(6):861-866.
90. Strouse J.J., Jordan L.C., Lanzkron S., Casella J.F. The excess burden of stroke in hospitalized adults with sickle cell disease. Am. J. Hematol. Sep 2009, 84(9):548-552.
91. Strouse J.J., Lanzkron S., Urrutia V. The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease. Expert. Rev. Hematol. Dec 2011, 4(6):597-606.